Design and Rationale of the Sevoflurane for Sedation in Acute Respiratory Distress Syndrome (SESAR) Randomized Controlled Trial.

Raiko Blondonnet , Laure-Anne Simand , Perine Vidal , Lucile Borao , Nathalie Bourguignon , Dominique Morand , Lise Bernard , Laurence Roszyk , Jules Audard , Thomas Godet , Antoine Monsel (1) , Marc Garnier , Christophe Quesnel , Jean-Etienne Bazin , Vincent Sapin , Julie A. Bastarache , Lorraine B. Ware , Christopher G. Hughes , Pratik P. Pandharipande , E. Wesley Ely , Emmanuel Futier , Bruno Pereira , Jean-Michel Constantin , Matthieu Jabaudon , On Behalf of The Sesar Collaborative Group

1 I3 - Immunologie - Immunopathologie - Immunothérapie [CHU Pitié Salpêtrière]

Domaines: Immunologie

Raiko Blondonnet, Laure-Anne Simand, Perine Vidal, Lucile Borao, Nathalie Bourguignon, et al.. Design and Rationale of the Sevoflurane for Sedation in Acute Respiratory Distress Syndrome (SESAR) Randomized Controlled Trial.. Journal of clinical medicine, 2022, 11, ⟨10.3390/jcm11102796⟩. ⟨hal-03967648⟩